Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Ulery, Bret D ^a   Petersen, Latrisha K ^a   Phanse, Yashdeep ^b   Kong, Chang Sun ^a   Broderick, Scott R ^a   Kumar, Devender ^c   Ramer Tait, Amanda E ^b   Carrillo Conde, Brenda ^a   Rajan, Krishna ^a   Wannemuehler, Michael J ^b   Bellaire, Bryan H ^b   Metzger, Dennis W ^c   Narasimhan, Balaji ^a  

^a Iowa State University of Science and Technology   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; NANOPARTICLE; POLYANHYDRIDE; VACCINE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CHEMISTRY; DENDRITIC CELL; DRUG DESIGN; FEMALE; MATERIALS TESTING; METHODOLOGY; MOUSE; NANOMEDICINE; STATISTICAL MODEL; YERSINIA PESTIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DRUG DESIGN; FEMALE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; MODELS, STATISTICAL; NANOMEDICINE; NANOPARTICLES; POLYANHYDRIDES; VACCINES; YERSINIA PESTIS;

EID: 84859761139     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00198     Document Type: Article

References (37)

1. Zepp, F. Principles of vaccine design-lessons from nature. Vaccine 28, C14-C24 (2010).
2. Moser, M. & Leo, O. Key concepts in immunology. Vaccine 28, C2-C13 (2010).
3. Kipper, M. J., Wilson, J. H., Wannemuehler, M. J., & Narasimhan, B. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J Biomed Mater Res A 76A, 798-810 (2006). (Pubitemid 47233489)
4. Pawar, D. et al. Evaluation of mucoadhesive PLGA microparticles for nasal immunization. Aaps J 12, 130-137 (2010).
5. Ulery, B. D. et al. Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS ONE 6, e17642 (2011).
6. Coeshott, C. M. et al. PluronicH F127-based systemic vaccine delivery systems. Vaccine 22, 2396-2405 (2004). (Pubitemid 38757336)
7. Andrianov, A. K., Townsend, H. & Mutwiri, G. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci USA 106, 18936-18941 (2009).
8. Wilson-Welder, J. H. et al. Vaccine adjuvants: Current challenges and future approaches. J Pharm Sci 98, 1278-316 (2009).
9. Determan, A. S. et al. Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J Control Release 100, 97-109 (2004). (Pubitemid 39445989)
10. Torres, M. P. et al. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 28, 108-16 (2007). (Pubitemid 44427910)
11. Petersen, L. K. et al. The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells. Biomaterials 30, 5131-5142 (2009).
12. Torres, M. P. et al. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. Acta Biomater 7, 2857-2864 (2011).
13. Ulery, B. D. et al. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm Res 26, 683-690 (2009).
14. Janeway, C. A., Travers, P., Shlomichik, M. J. & Walport, M. Immunobiology (Garland Science, New York, 2005).
15. InvivoGen, Agonistic and antagonistic effects of LPS on TLR4. www. invivogen. com (January 11 2011).
16. Gatti, E. & Pierre, P. Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr Opin Cell Biol 15, 468-473 (2003). (Pubitemid 36928050)
17. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 5, 1249-1255 (1999). (Pubitemid 29535601)
18. Hu, Y. et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett 7, 3056-3064 (2007).
19. Watts, C. Antigen processing in the endocytic compartment. Curr Opin Immunol 13, 26-31 (2001). (Pubitemid 32096956)
20. Gold, J. A. et al. CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun 71, 3521-8 (2003). (Pubitemid 36637581)
21. Bicerano, J. Predictions of Polymer Properties. (Marcel Dekker, New York; 1996).
22. Rodriguez-Torres, A. et al. Differential scanning calorimetry investigations on LPS and free lipids A of the bacterial cell wall. Res Microbiol 144, 729-40 (1993). (Pubitemid 24040917)
23. Ramos-Sanchez, M. C. et al. Thermolytical techniques to characterize fungal polysaccharides and bacterial lipopolysaccharides. Biotechnol Prog 7, 526-33 (1991).
24. Pearson, K. Mathematical contributions to the theory of evolutions. III. Regression, heredity, and panmixia. Philos Trans R Soc London A 187, 253-318 (1896).
25. Broderick, S. R., Nowers, J. R., Narasimhan, B. & Rajan, K. Tracking chemical processing pathways in combinatorial polymer libraries via data mining. J Comb Chem 12, 270-277 (2010).
26. Erridge, C., Bennett-Guerrero, E. & Poxton, I. R. Structure and function of lipopolysaccharides. Microbes Infect 4, 837-51 (2002). (Pubitemid 35247447)
27. Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25, 1159-64 (2007). (Pubitemid 47538111)
28. Carrillo-Conde, B. et al. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens. Acta Biomater 6, 3110-9 (2010).
29. Airhart, C. L., et al. Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Vaccine 26, 5554-5561 (2008).
30. Amemiya, K. et al. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonicmodels of plague. Vaccine 27, 2220-2229 (2009).
31. Huang, J. et al. Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine. Clin Vaccine Immunol 16, 719-25 (2009).
32. Diacovich, L. & Gorvel, J. P. Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol 8, 117-128 (2010).
33. Kasturi, S. P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543-7 (2011).
34. Kipper, M. J., Shen, E., Determan, A. & Narasimhan, B. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials 23, 4405-12 (2002).
35. Torres, M. P., Vogel, B. M., Narasimhan, B. & Mallapragada, S. K. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms. J Biomed Mater Res A 76, 102-10 (2006). (Pubitemid 43075687)
36. Guideline on validation of the Limulus amebocyte test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. Center for Drug Evaluation and Research. 1-10 (1987).
37. Rosipal, R. & Kramer, N. Subspace, Latent Structure and Feature Selection Techniques (Springer, Berlin/Heidelberg, 2006).